STM2457
STM2457 is a first-in-class, highly potent, selective and orally active METTL3 inhibitor with an IC50 of 16.9 nM. STM2457 can be used for the research of acute myeloid leukaemia (AML) [1][2].
Product Specifications
CAS Number
2499663-01-1
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; METTL3
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/stm2457.html
Purity
99.87
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C(N=C1N2C=CC=C1)=CC2=O)NCC3=CN4C=C(CNCC5CCCCC5)C=CC4=N3
Molecular Formula
C25H28N6O2
Molecular Weight
444.53
Precautions
H302, H315, H319, H335
References & Citations
[1]Wesley Peter Blackaby, et al. Mettl3 inhibitory compounds. WO2020201773A1.|[2]Eliza Yankova, et al. Small molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021 Apr 26.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470470-500 1x 500 µL
CD45 / LCA (2B11), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
![PE Anti-Human CD180 Antibody[MHR73-11]](https://cdn.genprice.uk/products/763/68dd14ad061270361e7d3434/imageurl08/an00326d.webp)